Kontaktujte nás

Jump to treatment group
Jump to language selector
Jump to navigation
Jump to Content
Jump to Footer

Vážení návštěvníci stránek. Pokud máte jakékoliv dotazy či připomínky ať již k obsahu stránek, tak přímo na společnost Lilly, či pokud Vám můžeme pomoci odbornou radou v některé z medicínských oblastí, kterými se zabýváme, neváhejte nás kontaktovat:

Eli Lilly
Pobřežní 12, 186 00 Praha 8
Tel.: +420 234 664 111, fax: +420 234 664 891
Internet: www.lilly.cz

Personální oddělení: cz_hr@lilly.com
Pokud chcete oznámit nežádoucí příhodu nebo máte-li podezření na závadu v jakosti týkající se našeho přípravku / zdravotnického prostředku, kontaktujte nás prosím telefonicky na výše uvedeném čísle nebo se můžete obrátit přímo na Státní ústav pro kontrolu léčiv www.sukl.cz (kontakty jsou v sekci Informace o SÚKL, pro urgentní případy nepřetržitá služba: urgent@sukl.cz ).

References

1. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.J Urol 1994;151: 54-61.
2. Lobb-Rossini K. Erectile dysfunction and its management. Journal of Community Nursing Online 1999;13 (10):1-8.
3. Eardley Ian, Sethia Krishna. Erectile Dysfunction. Current Investigations and Management. Second Edition. Moby. Pg 1.
4. Dey J, and Shepherd MD. Evaluation and Treatment of Erectile Dysfunction in Men With Diabetes Mellitus. Mayo Clin Proc 2002; 77: 276-82.
5. Kirby Roger, Carson Culley, Goldstein Irwin. Erectile dysfunction. A Clinical Guide. ISIS Medical Media. Pg 25.
6. A survey by Ghezzi and colleagues in 1995 indicated that 44 per cent of affected men had some sexual difficulty and 38 per cent had total erectile dysfunction Ghezzi et al. J Neurol, 1995 242 (3):123-6. Alternatively Up to 70-80% of men with MS may also experience erectile dysfunction Eardley Ian, Sethia Krishna. Erectile Dysfunction. Current Investigations and Management. Second Edition. Moby. Pg 3.
7. Kirby Roger, Carson Culley, Goldstein Irwin. Erectile dysfunction. A Clinical Guide. ISIS Medical Media. Pg 25.
8. Kupevian V, Araujo A et al. Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. Prev Med. 2010 Jan-Feb;50(1-2):19-25. Epub 2009 Nov 24.
9. Hannan JL, Maio MT et al. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. J Sex Med .2009 Mar;6 Suppl 3:254-61.
10. Jackson G. The importance of risk factor reduction in erectile dysfunction. Curr Urol Rep. 2007 Nov;8(6):463-6.
11. Kupelian V, Link CL, McKinlay JB. Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. Eur Urol. 2007 Aug;52(2):416-22. Epub 2007 Mar 16.
12. Miller T. Diagnostic evaluation of erectile dysfunction. Am Fam Physician, 2000; 61:95-104.
13. Reffelmann T, Kloner RA. Sexual function in hypertensive patients receiving treatment. Vasc Health Risk Manag. 2006;2(4):447-55.
14. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator Heart.2003 Mar;89(3):251-3.
15. Billups KL Erectile dysfunction as a marker for vascular disease.Curr Urol Rep. 2005 Nov;6(6):439-44.
16. Jackson G, Rosen RC et al. The Second Princeton Consensus on Sexual Dysfunction and Cardiac Risk: New Guidelines for Sexual Medicine. J Sex Med 2006; 3:28-36
17. Tamler R. Diabetes, obesity, and erectile dysfunction.Gend Med. 2009;6 Suppl 1:4-16.
18. Metabolic Syndrome.http://www.nhlbi.nih.gov/health/dci/Diseases/ms/ms_treatments.html
19. Porst H. Premature ejaculation. Urologe A 2009 Jun;48(6):663-74.
20. British National Formulary 58. http://bnf.org/bnf/bnf/current/
21. Safarinejad MR, Hosseini SY.Erectile dysfunction: clinical guidelines (2).Urol J. 2004;1(4):227-39.
22. Cialis Summary of Product Characteristics http://emc.medicines.org.uk/medicine/11363/SPC/Cialis+2.5mg%2c+5mg%2c+10mg+%26+20mg+film-coated+tablets/
23. Viagra Summary of Product Characteristics http://emc.medicines.org.uk/medicine/1474/SPC/Viagra+25mg%2c+50mg%2c+100mg/
24. Levitra Summary of Product Characteristics http://emc.medicines.org.uk/medicine/11775/SPC/Levitra+5mg%2c+10mg%2c+20mg+film-coated+tablets/
25. MUSE Summary of Product Characteristics http://emc.medicines.org.uk/medicine/22218/SPC/MUSE+1000+microgram+urethral+stick./
26. Caverject Dual Chamber Summary of Product Characteristics http://emc.medicines.org.uk/medicine/21200/SPC/Caverject+Dual+Chamber+10+micrograms+%26+Caverject+Dual+Chamber+20+micrograms/
27. Caverject powder for injection Summary of Product Characteristics http://emc.medicines.org.uk/medicine/1480/SPC/Caverject+Powder+for+Injection+5%2c+10%2c+20%2c+40+Micrograms/
28. Riley A. The role of the partner in erectile dysfunction and its treatment . Int J Impot Res. 2002 Feb;14 Suppl 1:S105-9.
29. Aytaç, Mckinlay & Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999; 84:50-6.
30. Wespes E. Amar E. Eardley I et al. Guidelines of Male Sexual Dysfunction. Eur Assoc Urol. 2009. http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/Male_Sexual_Dysf.pdf
31. European Sexual Dysfunction Alliance. http://www.essm.org/patient-area/erectile_dysf.asp#q2
32. Caverject powder for injection Patient Information Leaflet. http://emc.medicines.org.uk/searchresults.aspx?term=caverject&searchtype=QuickSearch
33. Safarinejad H. Erectile Dysfunction. Clinical Guidelines (1). Urol J, 2004, 3(1):133-147
34. Cancer Research UK Website – Prostate Cancer Treatment. http://info.cancerresearchuk.org/cancerstats/types/prostate/symptomstreatment/
35. Physical Activity and Public health Guidelines. American College of Sports Medicine. http://www.acsm.org/AM/Template.cfm?Section=Home_Page&TEMPLATE=CM/HTMLDisplay.cfm&CONTENTID=7764
36. Banks, Ian et al.; Assessment, in a General Population of Men, of Men’s Interaction With the Healthcare System to Obtain Phosphodiesterase Type 5 Inhibitors; 2008; Joint Congress of the European and International Societies for Sexual Medicine
37. European Alliance for Access to Safe Medicine; The Counterfeiting Superhighway; 2008
38. McNeil Jr., Donald G; A Growing Epidemic of Fake Medication in Asia; International Herald Tribune, February 20, 2007
39. Santamaría FC. Psycosocial features of the management of erectile dysfunction, Archivos Espnoles Urologia. 2010 Oct;63(8):693-702
40. European Association of Urology - www.urologyweek.org/erectile-dysfunction/erectile-dysfunction
41. Hedon F. Anxiety and erectile dysfunction: a global approach to ED enhances results and quality of life. International Journal of Impotence Resolution. 2003 Apr;15 Suppl 2:S16-9.
42. Mayo Clinic: Erectile dysfunction. www.mayoclinic.com/health/erectile-dysfunction/DS00162
43. Cleveland Clinic: Erectile Disorder. http://my.clevelandclinic.org/disorders/Erectile_Disorder_impotence/hic_Psychological_Causes_of_Erectile_Dysfunction.aspx
44. Steidle CP, Stecher VJ et al. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age. Curr Med Res Opin. 2006 May;22(5):939-48. http://www.ncbi.nlm.nih.gov/pubmed/16709315
45. Mayo Clinic: Relaxation techniques: Essential for reducing stress. http://www.mayoclinic.com/health/relaxation-technique/SR00007

Wybierz język

Navigation menu

Submenu

References